medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 1

<< Back Next >>

Ann Hepatol 2017; 16 (1)

Complications of Liver Resection in Geriatric Patients

Dedinská I, Laca L, Miklusica J, Palkoci B, Skálová P, Lauková S, Osinová D, Strmenová S, Janík J, Mokán M

Language: English
References: 30
Page: 149-156
PDF size: 151.48 Kb.


ABSTRACT

Introduction and aims. Liver resection is the treatment of choice for many primary and secondary liver diseases. Most studies in the elderly have reported resection of primary and secondary liver tumors, especially hepatocellular carcinoma and colorectal metastatic cancer. However, over the last two decades, hepatectomy has become safe and is now performed in the older population, implying a paradigm shift in the approach to these patients. Material and methods. We retrospectively evaluated the risk factors for postoperative complications in patients over 65 years of age in comparison with those under 65 years of age after liver resection (n = 360). The set comprised 127 patients older than 65 years (35%) and 233 patients younger than 65 years (65%). Results. In patients younger than 65 years, there was a significantly higher incidence of benign liver tumors (P = 0.0073); in those older than 65 years, there was a significantly higher incidence of metastasis of colorectal carcinoma to the liver (0.0058). In patients older than 65 years, there were significantly more postoperative cardiovascular complications (P = 0.0028). Applying multivariate analysis, we did not identify any independent risk factors for postoperative complications. The 12-month survival was not significantly different (younger versus older patients), and the 5-year survival was significantly worse in older patients (P = 0.0454). Conclusion. In the case of liver resection, age should not be a contraindication. An individualized approach to the patient and multidisciplinary postoperative care are the important issues.


REFERENCES

  1. Laporte GA, Kalil AN. Liver ressection in eldery patients. ABCD Arq Bras Cir Dig 2013; 26: 136-9.

  2. Brunken C, Rogiers X, Malago M. Is resection of colorectal liver metastases still justified in very elderly patients. Chirurg 1998; 69: 1334.

  3. Caratozzolo E, Massani M, Recordare A, Bonariol L, Baldessin M, Bassi N. Liver resection in elderly: comparative study between younger and older than 70 years patients. Outcomes and implications for therapy. G Chir 2007; 28: 419-24.

  4. Health and Walfare Canada. Health Promotion Survey: Ottawa: Health Welfare, Canada

  5. Hegyi L, Krajcík S. Geriatria. Herbena 2010; 608.

  6. Ersan T, Schwer WA. Perioperative Management of the Geriatric Patient 2013. Available from: http:// emedicine.medscape.com/article/285433-overview#showall

  7. Kassin MT, Owen RM, Perez SD. Risk Factors for 30-Day Hospital Readmission among General Surgery Patients 2012. Published Online: Doi: http://dx.doi.org/10.1016/ j.jamcollsurg.2012.05.024.

  8. Kroupa K. Chirurgická liecba primárnych a sekundárnych nádorov pecene. Gastrointestinálna onkológia, 1. vydanie, Bratislava: INFOMA Business Trading 2008. s. 175-84.

  9. Bhangui P, Adam R. Liver resection of colorectal metastases in elderly patients. Eur Oncol 2010; 6: 37-40.

  10. Seeff BD. Introduction: The burden of hepatocellular carcinoma. Gastroenterology 2004; 127(Suppl. 1): S1-S4.

  11. Howlader N, Noone AM, Krapcho M. SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, https://seer.cancer.goc/crs/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

  12. World Health Organization Cancer Incidence in Five Continents. Lyon: The World Health Organization and The International Agency for Research on Cancer; 2002.

  13. World Cancer Research Fund and American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.

  14. Ries LAG, Melbert D, Krapcho M. SEER cancer statistics review, 1975–2005. Bethesda, MD: 2008.

  15. National Institutes of Health What You Need To Know About Cancer of the Colon and Rectum.Bethesda, MD: U.S. Department of Health and Human Services & National Institutes of Health; 2006.

  16. American Cancer Society. Colorectal Cancer Facts & Figures Special Edition 2005. Oklahoma City, OK: American Cancer Society; 2005; Accessed May 26, 2009. Available from: http://www.cancer.org/docroot/STT/stt_0.asp

  17. Modlin IM, Champaneria MC, Chan AK, Kidd M. A three decade analysis of 3911 small intestinal neuroendocrine tumors: The rapid pace of no progress. Am J Gastroenterol 2007; 102: 1464-73.

  18. Junejo AM, Mason JM, Sheen AJ. Cardiopulmonary exercise testing for preoperative risk assessment before hepatic resection. Brit J Surg 2012; 99: 1097-104.

  19. Andres A, Toso CH, Moldovan B. Complications of elective liver resections in a center with low mortality: A simple score to predict morbidity. Arch Surg 2011; 146: 1246- 52.

  20. Eagle KA, Brundage BH, Chaitman BR. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation 1996; 93: 1278-317.

  21. Taner T, Atwell TD, Zhang L. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. HPB 2013; 15: 190-5.

  22. Mohan H, Nicholson P, Winter DC. Ablation for Neuroendocrine Liver Metastases: A Systematic Review. J Vasc Interv Radiol 2015; 26: 935-42.

  23. De Baere T, Deschamps F, Tsekilas L. GEP-NETS UPDATE: Interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur J Endocrinol 2015; 172: 151-66.

  24. Ewing J. Lymphoepithelioma. Am J Pathol 1929; 5: 99-108.

  25. Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF Jr., Cooper PH, Colby TV, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein- Barr viral genomes by in situ hybridization. Am J Surg Pathol 1989; 13: 625-31.

  26. Chan AW, Tong JH, Sung MY, Lai PB, To KF. Epstein-Barr virus- associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favorable outcome. Histopathology 2014; 65: 674-83.

  27. Chan AW, Tong JH, Pan Y, Chan SL, Wong GL, Wong VW, Lai PB, et al. Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome. Am J Surg Pathol 2015; 39: 304-12.

  28. Patel KR, Liu T, Vaccharajani N, Chapman WC, Brunt EM. Characterization of inflammatory (lymphoepithelioma-like) hepatocellular carcinoma. Arch Pathol Lab Med 2014; 138: 1193-202.

  29. Saleh R, DaCamara P, Radhi J, Boutross-Tadross O. Lymphoepithelioma- like carcinoma of the breast mimicking nodular sclerosing Hodgkin’s lymphoma. Breast J 2005; 11: 353-4.

  30. Calderaro J, Rousseau B, Amaddeo G, Mercey M, Charpy C, Constentin C, Luciani A, et al. Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features. Hepatology 2016; 64: 2038-46.




2020     |     www.medigraphic.com